1
ERRATA Hertz MI. The Registry of the International Society for Heart and Lung TransplantationIntroduction to the 2012 Annual Reports: New Leadership, Same Vision. J Heart Lung Transplant 2012 Oct;31(10): 1045-51. In the published version of the above article, one of the trans- plant centers is spelled incorrectly in the appendix. The correct name of the transplant center should appear as follows: Spectrum Health, Grand Rapids, MI. Fang JC DeMarco T Givertz MM Borlaug BA Lewis GD Rame JE Gomberg-Maitland M Murali S Frantz RP McGlothlin D Horn EM and Benza RL. WHO Pulmonary Hypertension Group 2: Pulmonary Hypertension Due to Left Heart Disease in the Adult. A consensus statement of the PH council of the ISHLT JHLT 2012. J Heart Lung Transplant. 2012 Sep;31(9):913-33. In the published version of the above article, there was an error in the second row, fourth column of Table 1. (B) Definitions used in the Description of Pulmonary Hypertension. The corrected table appears below. Table 1 (B) Definitions Used in the Description of Pulmonary Hypertension Nomenclature Description Physiologic definition Hemodynamic criteria in literature Pulmonary hypertension (PH) Sustained elevation of PAP at rest Pre-capillary, post-capillary, mixed, high flow state Mean PAP Z 25 mm Hg (2 SD above normal) Pulmonary arterial hypertension (PAH) PH with ‘normal’ left sided filling pressure Pre-capillary vasoconstriction, remodeling, thrombosis-in-situ Mean PAP Z 25 mm Hg PCW, LAP, LVEDP r 15 mm Hg PVR 4 3 WU Pulmonary venous hypertension (PVH) PH with elevated left sided filling pressure Post-capillary passive congestion Mean PAP Z 25 mm Hg PCW, LAP, LVEDP 4 15 mm Hg TPG r 12–15 mm Hg PVR r 2.5–3.0 WU Mixed PH or PH with elevated left sided filling pressure and pulmonary vascular resistance (PVH þ PAH) Pre- and post-capillary (passive congestion with excessive arterial vasoconstriction vascular remodeling) Mean PAP Z 25 mm Hg PH out-of-proportion to left sided filling pressure PCW, LAP, LVEDP 4 15 mm Hg TPG 4 12–15 mm Hg PVR 4 2.5–3.0 WU Reversible, reactive, or vasoreactive PH Component of mixed PH that is acutely or chronically responsive to pharmacologic (diuretics, vasodilators, inodilators) and/or mechanical circulatory support device therapies With vasodilators/inodilators: TPG r 12–15 mm Hg PVR r 2.5–3.0 WU Irreversible, fixed, refractory, or persistent PH Component of mixed PH that is not responsive to above strategies Despite vasodilators/inodilators: TPG 4 12–15 mm Hg PVR 4 2.5–3.0 WU High-flow PH PH with high cardiac output state or high pulmonary flow Pre-, post-, or mixed depending on etiology (eg, AV shunt, chronic anemia, congenital heart disease) Mean PAP Z 25 mm Hg PCWP, LAP, LVEDP variable TPG variable PVR variable High cardiac output AV, arteriovenous; LAP, left atrial pressure; LVEDP, left ventricular end diastolic pressure; PAP, pulmonary arterial pressure; PCWP, pulmonary capillary wedge pressure; PVR, peripheral vascular resistance; SD, standard deviation; TPG, transpulmonary gradient (mean PAP – PAWP).

Errata

  • Upload
    mi

  • View
    212

  • Download
    0

Embed Size (px)

Citation preview

Table 1 (B) Defi

Nomenclature

Pulmonary hyperte(PH)

Pulmonary arterialhypertension (P

Pulmonary venoushypertension (P

Mixed PH orPH out-of-proport

to left sided fillpressure

Reversible, reactivvasoreactive PH

Irreversible, fixed,refractory, orpersistent PH

High-flow PH

AV, arteriovenouswedge pressure; PVR

ERRATA

Hertz MI. The Registry of the International Society forHeart and Lung Transplantation—Introduction to the 2012Annual Reports: New Leadership, Same Vision. J HeartLung Transplant 2012 Oct;31(10): 1045-51.

nitions Used in the Description of Pulmonary Hyper

Description Physiolog

nsion Sustained elevation ofPAP at rest

Pre-capillmixed,

AH)PH with ‘‘normal’’ left sided filling

pressurePre-capill

remode

VH)PH with elevated left sided filling

pressurePost-capil

PH with elevated left sided fillingpressure and pulmonary vascularresistance (PVH þ PAH)

Pre- and(passivewith exvasoconremode

ioning

e, or Component of mixed PH that is acutely or chrto pharmacologic (diuretics, vasodilators, inmechanical circulatory support device thera

Component of mixed PH that is not responsiv

PH with high cardiac outputstate or high pulmonary flow

Pre-, poston etiochronicheart d

; LAP, left atrial pressure; LVEDP, left ventricular end diasto, peripheral vascular resistance; SD, standard deviation; TP

In the published version of the above article, one of the trans-plant centers is spelled incorrectly in the appendix. The correctname of the transplant center should appear as follows:

Spectrum Health, Grand Rapids, MI.

Fang JC DeMarco T Givertz MM Borlaug BA Lewis GDRame JE Gomberg-Maitland M Murali S Frantz RPMcGlothlin D Horn EM and Benza RL. WHO PulmonaryHypertension Group 2: Pulmonary Hypertension Due toLeft Heart Disease in the Adult. A consensus statement ofthe PH council of the ISHLT JHLT 2012. J Heart LungTransplant. 2012 Sep;31(9):913-33.

In the published version of the above article, there was anerror in the second row, fourth column of Table 1.(B) Definitions used in the Description of PulmonaryHypertension. The corrected table appears below.

tension

ic definition Hemodynamic criteria in literature

ary, post-capillary,high flow state

Mean PAP Z 25 mm Hg (2 SD abovenormal)

ary vasoconstriction,ling, thrombosis-in-situ

Mean PAP Z 25 mm HgPCW, LAP, LVEDP r 15 mm HgPVR 4 3 WU

lary passive congestion Mean PAP Z 25 mm HgPCW, LAP, LVEDP 4 15 mm HgTPG r 12–15 mm HgPVR r 2.5–3.0 WU

post-capillarycongestion

cessive arterialstriction � vascularling)

Mean PAP Z 25 mm HgPCW, LAP, LVEDP 4 15 mm HgTPG 4 12–15 mm HgPVR 4 2.5–3.0 WU

onically responsiveodilators) and/orpies

With vasodilators/inodilators:TPG r 12–15 mm HgPVR r 2.5–3.0 WU

e to above strategies Despite vasodilators/inodilators:TPG 4 12–15 mm HgPVR 4 2.5–3.0 WU

-, or mixed dependinglogy (eg, AV shunt,anemia, congenital

isease)

Mean PAP Z 25 mm HgPCWP, LAP, LVEDP variableTPG variablePVR variableHigh cardiac output

lic pressure; PAP, pulmonary arterial pressure; PCWP, pulmonary capillaryG, transpulmonary gradient (mean PAP – PAWP).